Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Glory Star New Media Group Holdings Limited (NASDAQ:GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional investors at $2.48 per share.
• Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares gained 108% to $3.29 after jumping 25% on Monday.
• BELLUS Health Inc. (NASDAQ:BLU) shares jumped 99.5% to $14.48 after GSK announced it will acquire the company for $14.75 per share in cash, representing an approximate total equity value of $2 billion.
• SAB Biotherapeutics, Inc. (NASDAQ:SABS) rose 79% to $1.38. The FDA granted Breakthrough Therapy Designation (BTD) to SAB Biotherapeutics SAB-176, an investigational therapy for post-exposure prophylaxis for Type A and Type B influenza illness in high-risk patients, including antiviral resistant strains.
• HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) gained 57.7% to $4.73 after the company reported key first quarter milestone achievements for drug discovery.
• Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 55% to $1.84.
• Super League Gaming, Inc. (NASDAQ:SLGG) surged 39% to $0.5949 after the company and LandVault announced a strategic partnership to provide brands with scalable solutions to bridge the gap between Web2 and Web3.
• Phio Pharmaceuticals Corp. (NASDAQ:PHIO) rose 38.3% to $8.13. Phio presented preclinical data showing synergy-enhanced in vivo anti-tumor efficacy of PD-1/CTLA-4 dual-targeting INTASYL.
• Gamida Cell Ltd. (NASDAQ:GMDA) climbed 33% to $1.49 after the U.S. Food and Drug Administration approved Gamida Cell’s allogeneic cell therapy, Omisirge® (omidubicel-onlv).
• Toro Corp. (NASDAQ:TORO) gained 29.4% to $4.2344.
• YS Biopharma Co., Ltd. (NASDAQ:YS) gained 26% to $1.99 after the company reported preliminary total revenue of $103 million, representing a year-over-year growth of 30%.
• Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) shares gained 25% to $4.8212.
• Trevi Therapeutics, Inc. (NASDAQ:TRVI) surged 17.1% to $2.1550. Needham reiterated Trevi Therapeutics with a Buy and maintained an $8 price target.
• Stronghold Digital Mining, Inc. (NASDAQ:SDIG) rose 16.4% to $1.1412.
• Angion Biomedica Corp. (NASDAQ:ANGN) gained 15.1% to $0.7447.
• Bed Bath & Beyond Inc. (NASDAQ:BBBY) climbed 15% to $0.3221 after gaining around 18% on Monday. Bed Bath & Beyond recently filed preliminary prospectus for resale of up to 111.7 million shares of common stock by B. Riley Principal Capital II.
• CleanSpark, Inc. (NASDAQ:CLSK) surged 11.3% to $4.8900 after gaining over 6% on Monday. CleanSpark recently announced the purchase of 45,000 units of the Antminer S19 XP bitcoin mining machines.
• LegalZoom.com, Inc. (NASDAQ:LZ) gained 10.9% to $10.25. JMP Securities upgraded LegalZoom.com from Market Perform to Market Outperform and announced a $14 price target.
• Sibanye Stillwater Limited (NYSE:SBSW) rose 10.7% to $9.52.
• Axcella Health Inc. (NASDAQ:AXLA) rose 10.4% to $0.4001.
• Altamira Therapeutics Ltd. (NASDAQ:CYTO) gained 10.3% to $1.22. Altamira Therapeutics recently announced the publication of results from its Phase 2 trial with AM-125 in acute vestibular syndrome in a leading peer reviewed journal.
• Riot Platforms, Inc. (NASDAQ:RIOT) rose 9.8% to $14.21 amid rise in Bitcoin prices.
• The Lion Electric Company (NYSE:LEV) gained 9% to $2.15.

Losers

• China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) shares fell 73.7% to $1.2499 after the company announced a $7 million registered direct offering.
• United Insurance Holdings Corp. (NASDAQ:UIHC) fell 54.6% to $1.58. United Insurance, last month, posted a Q4 loss of $6.33 per share.
• Blackboxstocks Inc. (NASDAQ:BLBX) fell 28% to $3.94. Blackboxstocks shares jumped 106% on Monday after the company announced it entered a letter of intent to merge with Evtec.
• Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) fell 26.4% to $0.4201 after jumping around 103% on Monday. Bellicum Pharmaceuticals recently discontinued Phase 1/2 trials and initiated an evaluation of strategic alternatives.
• Presto Automation Inc. (NASDAQ:PRST) fell 26.4% to $2.67 after jumping over 158% on Monday. Presto recently promoted Dan Mosher to President and Xavier Casanova to Chief Operating Officer.
• ContraFect Corporation (NASDAQ:CFRX) shares dropped 24.9% to $1.7207 after surging 154% on Monday. ContraFect recently announced initiation of a Phase 1b/2 study of exebacase in patients with chronic prosthetic joint infections of the knee.
• Pear Therapeutics, Inc. (NASDAQ:PEAR) fell 24.4% to $0.0361.
• Tempest Therapeutics, Inc. (NASDAQ:TPST) dropped 22.6% to $2.8250.
• Meta Data Limited (NASDAQ:AIU) fell 20.4% to $1.0020.
• CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) fell 20% to $2.20 after surging 17% on Monday.
• Digital Brands Group, Inc. (NASDAQ:DBGI) fell 17.5% to $1.22 following Q4 results. Digital Brands Group posted a Q4 loss of $20.46 per share.
• Evaxion Biotech A/S (NASDAQ:EVAX) fell 17.3% to $1.4399. Evaxion Biotech presented data from its Phase 1/2A study of its DNA-based personalized cancer immunotherapy, EVX-02 in combination with the checkpoint inhibitor nivolumab at the 2023 AACR Meeting.
• KWESST Micro Systems Inc. (NASDAQ:KWE) fell 17.4% to $2.55 after gaining 18% on Monday.
• Kiromic BioPharma, Inc. (NASDAQ:KRBP) dropped 14.7% to $4.09.
• Windtree Therapeutics, Inc. (NASDAQ:WINT) fell 13.6% to $7.15. Windtree Therapeutics shares surged 91% on Monday after the company announced the European Patent Office has granted Patent No. 3599243, providing patent coverage for the dual mechanism SERCA2a Activator class of drug candidates.
• AEye, Inc. (NASDAQ:LIDR) shares fell 11.7% to $0.2825 after climbing 35% on Monday.
• Relay Therapeutics, Inc. (NASDAQ:RLAY) dropped 11.5% to $16.12.
• Merus N.V. (NASDAQ:MRUS) fell 10.8% to $21.35.
• FiscalNote Holdings, Inc. (NYSE:NOTE) dropped 10.3% to $2.42.
• Oblong, Inc. (NASDAQ:OBLG) fell 8.2% to $1.9637 after dropping more than 20% on Monday.
• Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC) dropped 7.2% to $5.49 after the company reported Q1 financial results. The company also announced CFO Carl Mellander will step down at the end of the Q1 2024.

Now Read This: Wall Street's Most Accurate Analysts Say Sell These 3 Tech Stocks Delivering High-Dividend Yields